Key result
CMR detects focal myocardial fibrosis in 34% of patients with acute ischemic stroke.
Why the study?
Patients with acute ischemic stroke face high risks of adverse cardiovascular events, but the burden of CMR-derived myocardial injury in this population was not established.
What is the prevalence and pattern of myocardial injury detected by CMR in patients with acute ischemic stroke?
Observational (n=115)
No
What is the prevalence and pattern of myocardial injury detected by CMR in patients with acute ischemic stroke?
Over one-third of patients with acute ischemic stroke have evidence of focal myocardial fibrosis on CMR, with nearly half of these changes appearing acute or subacute.
May support targeted cardiac evaluation after stroke; leaves open whether CMR fibrosis detection improves outcomes.
BACKGROUND: Patients with acute ischemic stroke (AIS) are at high risk of adverse cardiovascular events. Until now, the burden of myocardial injury derived from cardiovascular magnetic resonance imaging (CMR) has not been established in this population. METHODS: Patients with AIS underwent CMR at 3 Tesla within 120 h after the index stroke as part of a prospective, single-center study. Patients with persistent atrial fibrillation were excluded. Morphology and function of both cardiac chambers and atria were assessed applying SSFP cine. Myocardial tissue differentiation was based on native and contrast-enhanced imaging including late gadolinium enhancement (LGE) after 0.15 mmol/kg gadobutrol for focal fibrosis and parametric T2- and T1-mapping for diffuse findings. To detect myocardial deformation global longitudinal (GLS), circumferential (GCS) and radial (GRS) strain was measured applying feature tracking. Cardiac troponin was measured using a high-sensitivity assay (99th percentile upper reference limit 14 ng/L). T2 mapping values were compared with 20 healthy volunteers. RESULTS: CMR with contrast media was successfully performed in 92 of 115 patients (mean age 74 years, 40% female, known myocardial infarction 6%). Focal myocardial fibrosis (LGE) was detected in 31 of 92 patients (34%) of whom 23/31 (74%) showed an ischemic pattern. Patients with LGE were more likely to have diabetes, prior myocardial infarction, prior ischemic stroke, and to have elevated troponin levels compared to those without. Presence of LGE was accompanied by diffuse fibrosis (increased T1 native values) even in remote cardiac areas as well as reduced global radial, circumferential and longitudinal strain values. In 14/31 (45%) of all patients with LGE increased T2-mapping values were detectable. CONCLUSIONS: More than one-third of patients with AIS have evidence of focal myocardial fibrosis on CMR. Nearly half of these changes may have acute or subacute onset. These findings are accompanied by diffuse myocardial changes and reduced myocardial deformation. Further studies, ideally with serial CMR measurements during follow-up, are required to establish the impact of these findings on long-term prognosis after AIS.
No takes yet. Share an insight, caveat, or question.
Błaszczyk et al. (2023) conducted an observational in Acute ischemic stroke (n=115). Cardiovascular magnetic resonance imaging (CMR) was evaluated on Focal myocardial fibrosis (late gadolinium enhancement). Cardiovascular magnetic resonance imaging detected focal myocardial fibrosis in 34% of patients with acute ischemic stroke, with 74% of these showing an ischemic pattern.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: